SCINAI IMMUNOTHERAPEUTICS LTD. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $0.01 per share for the 12-month period ending 2024-12-31, per its 20-F filed 2025-05-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2025-05-07
- SCINAI IMMUNOTHERAPEUTICS LTD. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2022 was $0.01.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2024-12-31 | $0.01 20-F · filed 2025-05-07 |
| 2023-12-31 | $0.80 20-F · filed 2024-05-15 |
| 2022-12-31 | $0.01 10-K · filed 2023-04-17 |